Danielle Watson - 22 Dec 2025 Form 4 Insider Report for HeartSciences Inc. (HSCS)

Signature
/s/ Danielle Watson
Issuer symbol
HSCS
Transactions as of
22 Dec 2025
Net transactions value
$0
Form type
4
Filing time
22 Dec 2025, 18:38:40 UTC
Previous filing
11 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Watson Danielle Chief Financial Officer C/O HEARTSCIENCES INC.,, 550 RESERVE STREET, SUITE 360, SOUTHLAKE /s/ Danielle Watson 22 Dec 2025 0001933818

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HSCS Restricted Stock Units Award $0 +15,000 $0.000000 15,000 22 Dec 2025 Common Stock 15,000 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units (the "RSUs") granted to the Reporting Person under the Issuer's 2023 Equity Incentive Plan (as amended, the "Plan") pursuant to the approval of the Issuer's board of directors. Each vested RSU shall be settled by delivery to the Reporting Person of one share of the Issuer's common stock, $0.001 par value per share, upon satisfaction of the Conditions (as defined below).
F2 The RSUs shall vest subject to the satisfaction of all of the following conditions (the "Conditions"): (i) approval by the Issuer's shareholders of any amendment or modification to or restatement of the Plan, which, among other things, contemplates the award of the RSUs, and (ii)(x) 1/3rd of the RSUs shall vest on the one-year anniversary of the grant date (the "Initial Vesting Date") and (y) thereafter, 1/12th of the RSUs shall vest on each subsequent quarterly anniversary of the Initial Vesting Date (each an "Additional Initial Vesting Date" and together with the Initial Vesting Date, the "Vesting Dates"), such that all of the RSUs shall fully vest on the three-year anniversary of the grant date, (continued to footnote 3)
F3 in each case provided that the Reporting Person is continuously employed by and is in good standing with the Issuer and the Reporting Person's employment agreement with the Issuer (the "Employment Agreement") is in effect, through each applicable Vesting Date. 100% of the RSUs shall vest (i) in the event of a Change of Control (as defined in the Plan) or (ii) if the Issuer achieves $250,000 or more of revenue in any fiscal quarter ending after the date hereof.

Remarks:

Chief Financial Officer